NO154054C - Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksypyrimidinderivater. - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksypyrimidinderivater.Info
- Publication number
- NO154054C NO154054C NO800664A NO800664A NO154054C NO 154054 C NO154054 C NO 154054C NO 800664 A NO800664 A NO 800664A NO 800664 A NO800664 A NO 800664A NO 154054 C NO154054 C NO 154054C
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- therapeutic active
- analogy procedure
- hydroxypyrimidine derivatives
- hydroxypyrimidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB7908494 | 1979-03-10 | ||
GB7914987 | 1979-04-30 |
Publications (3)
Publication Number | Publication Date |
---|---|
NO800664L NO800664L (no) | 1980-09-11 |
NO154054B NO154054B (no) | 1986-04-01 |
NO154054C true NO154054C (no) | 1986-07-09 |
Family
ID=26270867
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO800664A NO154054C (no) | 1979-03-10 | 1980-03-07 | Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksypyrimidinderivater. |
Country Status (24)
Country | Link |
---|---|
JP (1) | JPS55122768A (fi) |
AR (1) | AR222691A1 (fi) |
AU (1) | AU533547B2 (fi) |
BE (1) | BE881752A (fi) |
CA (1) | CA1132561A (fi) |
CH (1) | CH644368A5 (fi) |
DE (3) | DE3009071C2 (fi) |
EG (1) | EG14282A (fi) |
FI (1) | FI66357C (fi) |
FR (2) | FR2451370A1 (fi) |
GB (1) | GB2045756B (fi) |
HK (1) | HK55383A (fi) |
IE (1) | IE49547B1 (fi) |
IN (1) | IN153791B (fi) |
LU (1) | LU82185A1 (fi) |
MX (1) | MX6218E (fi) |
MY (1) | MY8400200A (fi) |
NL (1) | NL184833C (fi) |
NO (1) | NO154054C (fi) |
NZ (1) | NZ192927A (fi) |
OA (1) | OA06484A (fi) |
PT (1) | PT70882A (fi) |
SE (1) | SE435180B (fi) |
SG (1) | SG22683G (fi) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE894517A (fr) * | 1981-10-16 | 1983-01-17 | Sod Conseils Rech Applic | Nouveau derive de l'isopropylamino pyrimidine, sa preparation et composition therapeutiques a base de ses composes |
US4673677A (en) * | 1983-10-03 | 1987-06-16 | Pfizer Inc. | Method for treatment of gastrointestinal disorders |
US4554276A (en) * | 1983-10-03 | 1985-11-19 | Pfizer Inc. | 2-Amino-5-hydroxy-4-methylpyrimidine derivatives |
US4711888A (en) | 1985-07-24 | 1987-12-08 | Pfizer Inc. | Hydroxy and alkoxy pyrimidines |
WO1989000423A1 (en) * | 1987-07-09 | 1989-01-26 | Pfizer Inc. | 2-amino-5-hydroxy-4-pyrimidones |
US4910204A (en) * | 1988-06-28 | 1990-03-20 | Pfizer Inc. | 2-amino-5-hydroxy-4-pyrimidones |
HU206337B (en) * | 1988-12-29 | 1992-10-28 | Mitsui Petrochemical Ind | Process for producing pyrimidine derivatives and pharmaceutical compositions |
US5264435A (en) * | 1988-12-29 | 1993-11-23 | Mitsui Petrochemical Industries, Ltd. | Pyrimidines and their pharmaceutical acceptable salts, and their use as medicines |
US4940712A (en) * | 1989-05-26 | 1990-07-10 | Pfizer Inc. | Derivatives of hydroxyprimidines as leukotriene synthesis inhibitors |
US5270319A (en) * | 1991-09-09 | 1993-12-14 | Warner-Lambert Company | 5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents |
US5220025A (en) * | 1992-02-24 | 1993-06-15 | Warner-Lambert Company | 2-substituted amino-4, 6-di-tertiary-butyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents |
US5196431A (en) * | 1992-02-24 | 1993-03-23 | Warner-Lambert Company | 2-substituted amino-4, 6-di-tertiary-buthyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents |
US9133212B1 (en) * | 2005-06-15 | 2015-09-15 | Vanderbilt University | Inhibitors of hemeprotein-catalyzed lipid peroxidation |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB741667A (en) * | 1952-12-05 | 1955-12-07 | Ici Ltd | New pyrimidine derivatives |
GB756189A (en) * | 1954-02-01 | 1956-08-29 | Ici Ltd | New pyrimidine derivatives |
ZA711152B (en) * | 1970-03-02 | 1971-11-24 | Ici Ltd | Manufacture of pyrimidines |
GB1525995A (en) * | 1976-02-18 | 1978-09-27 | Soc D Etudes Prod Chimique | Aminopyrimidine salt |
-
1980
- 1980-02-12 IN IN103/DEL/80A patent/IN153791B/en unknown
- 1980-02-15 BE BE0/199421A patent/BE881752A/fr not_active IP Right Cessation
- 1980-02-20 NZ NZ192927A patent/NZ192927A/xx unknown
- 1980-02-20 LU LU82185A patent/LU82185A1/fr unknown
- 1980-02-26 FI FI800566A patent/FI66357C/fi not_active IP Right Cessation
- 1980-02-27 AR AR280106A patent/AR222691A1/es active
- 1980-02-29 PT PT70882A patent/PT70882A/pt unknown
- 1980-03-03 CH CH165080A patent/CH644368A5/fr not_active IP Right Cessation
- 1980-03-04 CA CA346,981A patent/CA1132561A/en not_active Expired
- 1980-03-04 NL NLAANVRAGE8001289,A patent/NL184833C/xx not_active IP Right Cessation
- 1980-03-07 IE IE477/80A patent/IE49547B1/en unknown
- 1980-03-07 GB GB8007908A patent/GB2045756B/en not_active Expired
- 1980-03-07 AU AU56248/80A patent/AU533547B2/en not_active Ceased
- 1980-03-07 SE SE8001812A patent/SE435180B/sv not_active IP Right Cessation
- 1980-03-07 NO NO800664A patent/NO154054C/no unknown
- 1980-03-09 EG EG131/80A patent/EG14282A/xx active
- 1980-03-10 JP JP2931280A patent/JPS55122768A/ja active Granted
- 1980-03-10 MX MX808702U patent/MX6218E/es unknown
- 1980-03-10 OA OA57049A patent/OA06484A/xx unknown
- 1980-03-10 DE DE3009071A patent/DE3009071C2/de not_active Expired
- 1980-03-10 DE DE3050999A patent/DE3050999C2/de not_active Expired
- 1980-03-10 FR FR8005278A patent/FR2451370A1/fr active Granted
- 1980-03-10 FR FR8005277A patent/FR2451191A1/fr active Granted
- 1980-04-30 DE DE19803016752 patent/DE3016752A1/de active Granted
-
1983
- 1983-04-28 SG SG226/83A patent/SG22683G/en unknown
- 1983-11-17 HK HK553/83A patent/HK55383A/xx unknown
-
1984
- 1984-12-30 MY MY200/84A patent/MY8400200A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO149102C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive trans-4-fenyl-1,2,3,4-tetrahydro-1-naftalenamin-derivater | |
NO158099C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater. | |
NO152899C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive glycerolderivater. | |
NO157817C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive glycinamidderivater. | |
NO156864C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive piperinderivater. | |
NO161117C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive cefalosporinderivater. | |
NO156787C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater. | |
NO152129C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive omega-cyan-1, omega-difenyl-azaalkanderivater | |
NO153569C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive merkaptoacetyl-prolin-derivater. | |
NO153496C (no) | Analogifremgangsmaate for fremstilling av fysiologisk aktive indolizin-derivater. | |
NO146396C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidinderivater. | |
NO159654C (no) | Analogifremgangsm te for fremstilling av terapeutisk aktive 2-guanidin-4-heteroaryltiazolderivater. | |
NO154054C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksypyrimidinderivater. | |
NO154013C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive sesquiterpenderivater. | |
NO160079C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-derivater. | |
NO158739C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-piperazinopyrimidinderivater. | |
NO160511C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklo-butanderivater. | |
NO160512C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater. | |
NO151660C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolderivater. | |
NO168478C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive vinylthioacetamido-oxacefalosporinderivater. | |
NO154052C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolon-derivater. | |
NO794318L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive spiro-kinolyl-hydantoin-derivater | |
NO154088C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive tetrahydrokinoliner. | |
NO801989L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidopyrimidiner | |
NO152839C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater. |